Contact us
Schedule a Demo

CPT Code 43251 Complete Billing & Coding Guide for EGD With Snare Removal of Lesions

best medical billing company

Seamless Global Period Tracking and Compliance

Accurate OB Contract Management and Patient Collections

Upper endoscopy for the removal of an abnormal tissue of the upper gastrointestinal tract is frequently reported using CPT 43251. The accuracy of coding relies on the proper documentation of the location of the lesion, how it was removed and the medical necessity for the intervention. 

Complete removal of the lesion should be documented with a snare technique and not with biopsy or hot biopsy forceps, as therapeutic endoscopic procedures are often reviewed by payers. Compliance and claim denials are lessened with thorough documentation. 

For practices that use Gastroenterology Billing Services, there is a potential to benefit from coding review and documentation validation processes that can help guarantee claim accuracy and help improve reimbursement performance. 

CPT 43251 Description

Official Definition:
"Esophagogastroduodenoscopy, flexible, transoral; with removal of tumor(s), polyp(s), or other lesion(s) by snare technique."

CPT 43251 describes a therapeutic upper gastrointestinal endoscopy in which a flexible endoscope is advanced through the mouth to examine the esophagus, stomach, and duodenum. During the procedure, one or more tumors, polyps, or other lesions are removed using a snare device that encircles and excises the targeted tissue.

The snare technique may utilize electrocautery to facilitate removal and control bleeding. The diagnostic EGD portion is included in the code and should not be reported separately.

The service includes

  • Flexible transoral esophagogastroduodenoscopy (EGD)
  • Examination of the esophagus, stomach, and duodenum
  • Identification of tumors, polyps, or other lesions
  • Removal of one or more lesions using a snare technique
  • Retrieval of excised tissue when performed
  • Assessment of the treatment site following removal

However, CPT 43251 does not include

  • Separate reporting of the diagnostic EGD
  • Simple tissue biopsy
  • Lesion removal using hot biopsy forceps
  • The ability of patients to control bleeding without removing lesions 
  • Endoscopic ablation procedures

Clinical Indications for CPT 43251

CPT 43251 is typically reported when abnormal tissue within the upper gastrointestinal tract requires therapeutic removal. The procedure may be performed to treat symptoms, prevent complications, or obtain complete excision of suspicious lesions.

Common indications include

  • Gastric polyps
  • Duodenal polyps
  • Esophageal polyps
  • Benign gastrointestinal tumors
  • Stomatitis and upper GI lesions, especially those that are suspicious.
  • Symptoms resulting in bleeding lesions
  • The amount of tissue that is obstructed because of lesions.
  • The results of surveillance for which the children must be removed. 

The procedure may also be performed when abnormal growths are identified during diagnostic endoscopy and immediate removal is clinically appropriate.

Reimbursement Insights for CPT 43251

CPT code 43251 is typically reimbursed based on the therapeutic use of the procedure and the medical necessity associated with the removal of lesions. Documentation should be clear that the lesion was removed as opposed to sampled with biopsy alone. 

Key reimbursement considerations

  • Medically necessary and covered by Medicare and most commercial payers.
  • Reimbursement is usually greater for reimbursable services than diagnostic EGD services. 
  • Global period: 000 days
  • Diagnostic EGD is bundled into CPT 43251
  • Multiple lesions removed using the same technique during a single session are typically reported with one unit of service
  • Payment varies according to payer contracts, geographic region, and site of service
  • Separate facility reimbursement could be available for hospital outpatient departments and ASCs. 

Applicable Modifiers for CPT 43251

The modifier should accurately represent the circumstances of the procedure and any services rendered during the same encounter. All modifiers should be supported with documentation. 

Common modifiers

  • Modifier -51: Used when two or more procedures are done in the same operative session.
  • Modifier -59 or X{EPSU}: Used when a separate procedural service is provided at a separate site or under different circumstances that warrant separate reporting. 
  • Modifier -22: Used when the procedure requires substantially greater effort than normally expected and supporting documentation is provided.
  • Modifier -52: Used when the planned service is partially reduced.
  • Modifier -53: Used when the procedure is discontinued due to patient safety concerns or technical limitations.
  • Modifier -78: Used for an unplanned return to the procedure room during the postoperative period.
  • Modifier -79: Used when an unrelated procedure is performed during the postoperative period.

Important billing rule

CPT 43251 includes the diagnostic EGD component and should not be reported with CPT 43235 during the same procedure session.

Documentation Requirements for CPT 43251

Completing documentation is vital for code selection, medical necessity and payer compliance. The procedure report should provide a clear description of the lesion and be sure to document that the lesion was snared. 

Documentation should include

  • Medical indication for lesion removal
  • Location of each lesion
  • Number of lesions removed
  • Size and appearance of lesions when documented
  • Snare removal technique utilized
  • Use of electrocautery when applicable
  • Specimen retrieval details
  • Findings Conclusions after the removal of lesions.
  • Any complications or bleeding that occurs
  • Patient's acceptability of procedure.
  • Final procedure report, signed.

Documentation should clearly distinguish lesion removal from diagnostic biopsy procedures to support accurate code assignment.

Example Clinical Scenarios

Scenario 1: Gastric Polyp Removed by Snare Technique

Upper endoscopy is performed in a 63-year-old patient who had previously had an imaging test and a gastric polyp was found. The gastroenterologist extracts the polyp with a snare device during EGD, and takes the polyp for pathological examination. 

Coding Outcome: CPT 43251

Rationale: A gastric lesion was excised via EGD snare. 

Scenario 2: Duodenal Polyp Excision During Endoscopy

A patient comes for surveillance endoscopy because of past history of gastrointestinal polyps. During the examination, a duodenal polyp is identified and completely removed using snare excision. 

Coding Outcome: CPT 43251

Rationale: Therapeutic removal of a duodenal lesion by snare technique supports CPT 43251.

Scenario 3: Esophageal Lesion Removed for Pathologic Evaluation

At the upper endoscopy, a suspicious lesion in the esophagus is found. Then the doctor completely removes the snare from the lesion and submits the specimen to the pathologist for evaluation. 

Coding Outcome: CPT 43251

Rationale: Esophageal lesion was completely excised by snare technique. 

Scenario 4: Procedure Discontinued Due to Bleeding Risk

Planned removal of a large lesion in the stomach using a snare. Partial treatment is performed, and a significant bleeding risk is noted, and the doctor decides to discontinue the procedure prior to complete removal. 

Coding Outcome: CPT 43251-53

Rationale: Procedure discontinued prior to completion for patient safety reasons, supported by modifier -53. 

BillingFreedom Driving 97%+ First-Pass Claim Accuracy in GI Billing

BillingFreedom's team provides support for gastroenterology practices to improve the accuracy and completeness of coding for therapeutic endoscopy where detailed documentation and careful code selection are crucial. When performing services that require lesion removal, it is important to distinguish between biopsy, excision and snare procedures to ensure appropriate reimbursement.

Our billing specialists are dedicated to reviewing procedural documentation prior to claim submission to help practices eliminate procedural coding inconsistencies and avoid unnecessary claim problems. We integrate with clinical reporting requirements, helping you to ensure that billing cycles are seamless and reimbursement is optimized. 

Key Revenue Cycle Performance Metrics

BillingFreedom ensures code accuracy and compliance with standards while prioritizing performance in billing processes to maximize reimbursement efficiency. 

  • High first-pass claim acceptance rate, consistently at 97% – 99%, which facilitates quicker claim resolution. 
  • Maintain Preventable denial rate at below 1%, which helps to safeguard the practice revenue. 
  • Clean claim submission accuracy exceeding 95%, improving payer acceptance rates
  • Internal coding validation accuracy above 98%, supporting documentation and coding consistency
  • Continuous quality review processes which reduce billing errors and claim corrections 

This approach ensures gastroenterology practices are more efficient and more likely to have a successful reimbursement experience.

Discover more about our Gastroenterology Billing Services and how we can support GI practices achieve accurate coding and better reimbursement outcomes. 

For more details about our Gastroenterology medical billing services, please don't hesitate to contact us by email at info@billingfreedom.com or call us at +1 (855) 415-3472. 

It is our top priority to give you financial peace of mind!